Basis of Financial Statement Presentation (Details) (USD $)	6 Months Ended
	Jun. 30, 2012
June 1993 Common stock issued	14,589,775
June 1993 percentage of Sanguine California Subsidiary acquired	94.00%
December 2001 percentage of Sanguine California Subsidiary acquired	6.00%
Shares issued in exchange for 6% of Sanguine California subsidiary	840,195
Amount transferred for Sanguine Lifescience use	$ 15,000